Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia
Open Journal of Rheumatology and Autoimmune Diseases · 2012
DOI: 10.4236/ojra.2012.23011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Journal of Rheumatology and Autoimmune Diseases, 2012. Verfasst von Eric L. Matteson und 5 weiteren Autor:innen. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Matteson, E. L., Bongartz, T., Ryu, J. H., Crowson, C. S., Hartman, T. E., & Dellaripa, P. F. (2012). Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia. Open Journal of Rheumatology and Autoimmune Diseases. https://doi.org/10.4236/ojra.2012.23011
Vancouver
Matteson EL, Bongartz T, Ryu JH, Crowson CS, Hartman TE, Dellaripa PF. Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia. Open Journal of Rheumatology and Autoimmune Diseases. 2012. doi:10.4236/ojra.2012.23011
BibTeX
@article{Matteson2012,
author = {Matteson, Eric L. and Bongartz, Tim and Ryu, Jay H. and Crowson, Cynthia S. and Hartman, Thomas E. and Dellaripa, Paul F.},
title = {Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia},
journal = {Open Journal of Rheumatology and Autoimmune Diseases},
year = {2012},
doi = {10.4236/ojra.2012.23011}
}
EUVIMED